Lawrence Dultz
Pulmonary Disease · Terre Haute, INNPI 1255448916
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,825 and has fallen 88.4% since, to $212 in 2021. That places this record below the midpoint for pulmonary disease clinicians in IN, where the typical reported total is $2,226.
Across 130 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$475
- Boehringer Ingelheim$272
- Fisher & Paykel Healthcare Inc$230
- Sunovion Pharmaceuticals Inc.$203
- Regeneron Healthcare Solutions, Inc.$187
- United Therapeutics Corporation$160
- plus $579 from 15 others
What the payments were for
- Food & beverage$2,08399%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 37 | $475 |
| Boehringer Ingelheim | 18 | $272 |
| Fisher & Paykel Healthcare Inc | 2 | $230 |
| Sunovion Pharmaceuticals Inc. | 30 | $203 |
| Regeneron Healthcare Solutions, Inc. | 4 | $187 |
| United Therapeutics Corporation | 5 | $160 |
| AstraZeneca | 6 | $143 |
| Novartis | 4 | $73 |
| Philips North America LLC | 3 | $52 |
| Shire North American Group Inc | 3 | $46 |
| Mylan Specialty L.p. | 2 | $39 |
| Advanced Respiratory, Inc | 2 | $37 |
| Bayer | 2 | $29 |
| Insmed, Inc. | 2 | $28 |
| Merck | 2 | $26 |
| Genentech USA, Inc. | 2 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Pulmonx Corporation | 1 | $18 |
| Veran Medical Technologies, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $15 |
| Electromed, Inc. | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,106 in reported general payments places this provider in the 45th percentile of 258 pulmonary disease providers in Indiana.
Other pulmonary disease in Terre Haute
- Ajay DeshpandeTerre Haute$304K
- Anand BhuptaniTerre Haute$50K
- David MaresAnderson$1.3M
- David WilsonSeymour$689K
- Giovanni InfusinoCrown Point$526K
- Faisal KhanGreenwood$207K
- Sandeep KukrejaGreenwood$206K
- Raja DevanathanHobart$193K
- Asaad JandaliMunster$161K
- Gaurav KumarPortage$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.